arrow
Return

A CDK activity buffer ensures mitotic completion

delete2022-06-21
delete1
delete
OA
AI
S
Souradeep Basu *
J
James O. Patterson
T
Theresa U. Zeisner
P
Paul Nurse
DOI:10.1242/jcs.259626delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
The eukaryotic cell cycle is driven by the activity of cyclin-dependent kinases (CDKs). CDK activity rises over 50-fold during the cell cycle, from a low level in G1 to a high level in mitosis. However, it is not known whether the entire range of CDK activity is necessary for cell cycle progression, or whether cells can tolerate a reduction in CDK activity level. Here, in fission yeast, we show that sublethal CDK inhibition lengthens the time cells spend in mitosis but does not cause misordering of mitotic events. Maximum attainable CDK activity exceeds the amount necessary for mitosis, and thus forms a CDK activity buffer between sufficient and maximal possible CDK activities. This CDK activity buffer is needed for mitotic completion when CDK activity is compromised, and CDK inhibition only becomes lethal to cells when this buffer is exhausted. Finally, we explore what factors influence this CDK activity buffer, and find that it is influenced by CDK-counteracting phosphatases. Therefore, maximum attainable CDK activity is not necessary for mitosis but provides robustness to CDK activity reduction to ensure mitotic completion.
Keywords:
Cyclin-dependent kinase
CDK inhibitor
Cdk1
Mitosis
Kinase activity
Schizosaccharomyces pombe
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Journal of Cell Science cover
Journal of Cell Science
IF:
3.6
Papers:
1.1W
Citations:
3.7W

Organization

F
Francis Crick Institute
Scholars:
4.3K
Papers: 2.4K
Citations: 8.9K
Cited Papers

Cited Papers

errShare
errSave
Noninvasive Assessment of Endothelial Function: The Classic Methods and the New Peripheral Arterial Tonometry
err2014-08-01
err0
PREAI
errEnrico Vizzardi; Mara Gavazzoni; Paolo Della Pina; Ivano Bonadei; Valentina Regazzoni; Edoardo Sciatti; Eleftheria Trichaki; Riccardo Raddino; Marco Metra
errShare
errSave
errShare
errSave
Integrated safety in tocilizumab clinical trials
err2011-09-01
err0
errOAAI
errMichael H Schiff; Joel M Kremer; Angelika Jahreis; Emma Vernon; John D Isaacs; Ronald F van Vollenhoven
errShare
errSave
errShare
errSave
errShare
errSave
The Hydrophobic Patch Directs Cyclin B to Centrosomes to Promote Global CDK Phosphorylation at Mitosis
err2020-03-01
err17
errOAAI
errBasu, Souradeep; Roberts, Emma L.; Jones, Andrew W.; Swaffer, Matthew P.; Snijders, Ambrosius P.; Nurse, Paul
errShare
errSave
Robust Ordering of Anaphase Events by Adaptive Thresholds and Competing Degradation Pathways
err2015-11-01
err28
PREAI
errKamenz, Julia; Mihaljev, Tamara; Kubis, Armin; Legewie, Stefan; Hauf, Silke
errShare
errSave
researcher View more